DD292460A5 - Verfahren zur herstellung von 1,3-substituiertem tetrahydro-1h-thieno-[3,4-d]-imidazol-2(3h)-on-4-yliden-pentansaeureester - Google Patents
Verfahren zur herstellung von 1,3-substituiertem tetrahydro-1h-thieno-[3,4-d]-imidazol-2(3h)-on-4-yliden-pentansaeureester Download PDFInfo
- Publication number
- DD292460A5 DD292460A5 DD90338550A DD33855090A DD292460A5 DD 292460 A5 DD292460 A5 DD 292460A5 DD 90338550 A DD90338550 A DD 90338550A DD 33855090 A DD33855090 A DD 33855090A DD 292460 A5 DD292460 A5 DD 292460A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- group
- substituted
- thieno
- unsubstituted
- formula
- Prior art date
Links
- FOIMGWXSRXJOEX-UHFFFAOYSA-N 2-(2-oxo-3,3a,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-4-ylidene)pentanoic acid Chemical class N1C(NC2C1CSC2=C(C(=O)O)CCC)=O FOIMGWXSRXJOEX-UHFFFAOYSA-N 0.000 title claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- -1 phosphonium compound Chemical class 0.000 claims description 14
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 239000002585 base Substances 0.000 claims description 6
- 239000012442 inert solvent Substances 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 150000004714 phosphonium salts Chemical class 0.000 claims description 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 3
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims description 3
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000003638 chemical reducing agent Substances 0.000 claims description 3
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 3
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims description 3
- 125000004665 trialkylsilyl group Chemical group 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 2
- UORVGPXVDQYIDP-BJUDXGSMSA-N borane Chemical class [10BH3] UORVGPXVDQYIDP-BJUDXGSMSA-N 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 150000002440 hydroxy compounds Chemical class 0.000 claims description 2
- 239000012279 sodium borohydride Substances 0.000 claims description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 2
- VBKPPDYGFUZOAJ-UHFFFAOYSA-N 5-oxopentanoic acid Chemical compound OC(=O)CCCC=O VBKPPDYGFUZOAJ-UHFFFAOYSA-N 0.000 claims 3
- AZWXAPCAJCYGIA-UHFFFAOYSA-N bis(2-methylpropyl)alumane Chemical compound CC(C)C[AlH]CC(C)C AZWXAPCAJCYGIA-UHFFFAOYSA-N 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract description 10
- 239000000543 intermediate Substances 0.000 abstract description 4
- 239000013543 active substance Substances 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 4
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 238000007239 Wittig reaction Methods 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 101100202589 Drosophila melanogaster scrib gene Proteins 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- JLNULERJWNPXRW-UHFFFAOYSA-N N=1C(NC(C=1)=C(C(=O)O)CCC)=O Chemical compound N=1C(NC(C=1)=C(C(=O)O)CCC)=O JLNULERJWNPXRW-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- YZJCDVRXBOPXSQ-UHFFFAOYSA-N benzyl pentanoate Chemical compound CCCCC(=O)OCC1=CC=CC=C1 YZJCDVRXBOPXSQ-UHFFFAOYSA-N 0.000 description 1
- XGIUDIMNNMKGDE-UHFFFAOYSA-N bis(trimethylsilyl)azanide Chemical compound C[Si](C)(C)[N-][Si](C)(C)C XGIUDIMNNMKGDE-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- ZREIXECYDRCUTO-UHFFFAOYSA-N hexyl 5-oxopentanoate Chemical compound CCCCCCOC(=O)CCCC=O ZREIXECYDRCUTO-UHFFFAOYSA-N 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- YBTZROCKNUIONO-UHFFFAOYSA-N methyl 5-oxopentanoate Chemical compound COC(=O)CCCC=O YBTZROCKNUIONO-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- AVCVDUDESCZFHJ-UHFFFAOYSA-N triphenylphosphane;hydrochloride Chemical compound [Cl-].C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 AVCVDUDESCZFHJ-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH95389 | 1989-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD292460A5 true DD292460A5 (de) | 1991-08-01 |
Family
ID=4199016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD90338550A DD292460A5 (de) | 1989-03-15 | 1990-03-09 | Verfahren zur herstellung von 1,3-substituiertem tetrahydro-1h-thieno-[3,4-d]-imidazol-2(3h)-on-4-yliden-pentansaeureester |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5084578A (ja) |
| EP (1) | EP0387747B1 (ja) |
| JP (1) | JPH02282388A (ja) |
| AT (1) | ATE122676T1 (ja) |
| CA (1) | CA2011793A1 (ja) |
| DD (1) | DD292460A5 (ja) |
| DE (1) | DE59009076D1 (ja) |
| DK (1) | DK0387747T3 (ja) |
| ES (1) | ES2072326T3 (ja) |
| FI (1) | FI95034C (ja) |
| GE (1) | GEP19970939B (ja) |
| HU (1) | HU203892B (ja) |
| IE (1) | IE67771B1 (ja) |
| IL (1) | IL93730A (ja) |
| LT (1) | LT3192B (ja) |
| NO (1) | NO174151C (ja) |
| PT (1) | PT93437B (ja) |
| RU (1) | RU1838314C (ja) |
| YU (1) | YU45190A (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252743A (en) * | 1989-11-13 | 1993-10-12 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
| CN109503620B (zh) * | 2018-12-25 | 2020-10-16 | 浙江新和成股份有限公司 | 5-(2-氧代四氢噻吩并咪唑-4(2h)-烯基)戊酸类化合物的制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2784191A (en) * | 1957-03-05 | Process for the production of lactams | ||
| US2489232A (en) * | 1949-11-22 | Synthesis of biotin | ||
| US2489235A (en) * | 1947-07-24 | 1949-11-22 | Hoffmann La Roche | Synthesis of biotin |
| US2535010A (en) * | 1948-10-02 | 1950-12-19 | Rohm & Haas | Transetherification of beta-ethersubstituted esters |
| DE850007C (de) * | 1950-12-22 | 1952-09-22 | Basf Ag | Verfahren zur Herstellung von N-Aryl-ª‡-pyrrolidonen |
| BE759512A (fr) * | 1969-11-29 | 1971-05-27 | Hoffmann La Roche | Lactone |
| US4054740A (en) * | 1974-12-24 | 1977-10-18 | Hoffmann-La Roche Inc. | Hydroxybiotin |
| IT1045043B (it) * | 1975-08-13 | 1980-04-21 | Isf Spa | Derivati pirrolidinici |
| JPS6050455B2 (ja) * | 1976-07-16 | 1985-11-08 | オリンパス光学工業株式会社 | 内視鏡 |
| JPS5315074A (en) * | 1976-07-28 | 1978-02-10 | Nippon Telegr & Teleph Corp <Ntt> | Mask alignment method |
| IT1075564B (it) * | 1977-02-11 | 1985-04-22 | Isf Spa | Procedimento per la preparazione di derivati pirrolidinici |
| IT1075280B (it) * | 1977-02-11 | 1985-04-22 | Isf Spa | Procedimento per la preparazione di derivati pirrolidinici |
| DE3018109A1 (de) * | 1980-05-12 | 1981-11-19 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von biotin sowie neue ausgangsverbindungen fuer dieses verfahren |
| JPS5812272B2 (ja) * | 1981-04-28 | 1983-03-07 | 電気化学工業株式会社 | ４−ヒドロキシ−２−ピロリドンの製造法 |
| JPS58124791A (ja) * | 1982-01-19 | 1983-07-25 | Sumitomo Chem Co Ltd | ビオチンの製造法 |
| DE3580390D1 (de) * | 1984-05-18 | 1990-12-13 | Hoffmann La Roche | Verfahren zur herstellung eines lactons. |
| DE3575717D1 (de) * | 1984-08-25 | 1990-03-08 | Merck Patent Gmbh | Verfahren zur herstellung von (3a5,6ar)-und/oder(3ar,6a5)-1,3-dibenzyl-hexahydro-1h-furo(3,4-d)imidazol-2,4-dion. |
| DE3505652A1 (de) * | 1985-02-19 | 1986-08-21 | I.G. Bauerhin GmbH elektro-technische Fabrik, 6466 Gründau | Verfahren zum elektrischen beheizen von insbesondere fahrzeugsitzen |
| FI83510C (fi) * | 1985-02-22 | 1991-07-25 | Ciba Geigy Ag | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara bi-2h- pyrroli(di)ndioner. |
| CH670644A5 (ja) * | 1986-12-18 | 1989-06-30 | Lonza Ag | |
| CH671227A5 (ja) * | 1986-12-02 | 1989-08-15 | Lonza Ag | |
| US5236252A (en) * | 1991-12-18 | 1993-08-17 | Alliedsignal Inc. | Method of skid dection without speed sensors |
-
1990
- 1990-02-16 FI FI900787A patent/FI95034C/fi not_active IP Right Cessation
- 1990-03-06 YU YU00451/90A patent/YU45190A/xx unknown
- 1990-03-08 CA CA002011793A patent/CA2011793A1/en not_active Abandoned
- 1990-03-08 IE IE83690A patent/IE67771B1/en not_active IP Right Cessation
- 1990-03-09 JP JP2059786A patent/JPH02282388A/ja active Pending
- 1990-03-09 DD DD90338550A patent/DD292460A5/de not_active IP Right Cessation
- 1990-03-12 DE DE59009076T patent/DE59009076D1/de not_active Expired - Fee Related
- 1990-03-12 EP EP90104620A patent/EP0387747B1/de not_active Expired - Lifetime
- 1990-03-12 AT AT90104620T patent/ATE122676T1/de active
- 1990-03-12 ES ES90104620T patent/ES2072326T3/es not_active Expired - Lifetime
- 1990-03-12 DK DK90104620.1T patent/DK0387747T3/da not_active Application Discontinuation
- 1990-03-12 US US07/491,589 patent/US5084578A/en not_active Expired - Fee Related
- 1990-03-13 IL IL9373090A patent/IL93730A/en not_active IP Right Cessation
- 1990-03-14 RU SU904743316A patent/RU1838314C/ru active
- 1990-03-14 PT PT93437A patent/PT93437B/pt not_active IP Right Cessation
- 1990-03-14 HU HU901581A patent/HU203892B/hu not_active IP Right Cessation
- 1990-03-14 NO NO901190A patent/NO174151C/no unknown
- 1990-07-23 US US07/556,187 patent/US5086185A/en not_active Expired - Fee Related
-
1993
- 1993-02-26 LT LTIP359A patent/LT3192B/lt not_active IP Right Cessation
- 1993-07-12 GE GEAP19931002A patent/GEP19970939B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| YU45190A (en) | 1991-10-31 |
| EP0387747B1 (de) | 1995-05-17 |
| US5086185A (en) | 1992-02-04 |
| FI900787A0 (fi) | 1990-02-16 |
| HU203892B (en) | 1991-10-28 |
| CA2011793A1 (en) | 1990-09-15 |
| LT3192B (en) | 1995-03-27 |
| FI95034B (fi) | 1995-08-31 |
| US5084578A (en) | 1992-01-28 |
| PT93437A (pt) | 1990-11-07 |
| GEP19970939B (en) | 1997-03-26 |
| DE59009076D1 (de) | 1995-06-22 |
| PT93437B (pt) | 1996-08-30 |
| IL93730A (en) | 1996-01-19 |
| ATE122676T1 (de) | 1995-06-15 |
| RU1838314C (ru) | 1993-08-30 |
| EP0387747A1 (de) | 1990-09-19 |
| NO901190D0 (no) | 1990-03-14 |
| IL93730A0 (en) | 1990-12-23 |
| HU901581D0 (en) | 1990-06-28 |
| IE900836L (en) | 1990-09-15 |
| NO174151B (no) | 1993-12-13 |
| JPH02282388A (ja) | 1990-11-19 |
| IE67771B1 (en) | 1996-04-17 |
| LTIP359A (en) | 1994-09-25 |
| NO174151C (no) | 1994-03-23 |
| DK0387747T3 (da) | 1995-06-06 |
| ES2072326T3 (es) | 1995-07-16 |
| NO901190L (no) | 1990-09-17 |
| FI95034C (fi) | 1995-12-11 |
| HUT55398A (en) | 1991-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2759033C2 (de) | Verfahren zur Herstellung von 4-Hydroxypyrrolidin-2-on-1-ylalkylcarbonsäureamiden | |
| DE69632194T2 (de) | Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung | |
| EP1644314B1 (de) | Verfahren zum herstellen von difluoracetessigs urealkylestern | |
| EP0273270B1 (de) | Verfahren zur Herstellung von (+)-Biotin | |
| DE102004025072A1 (de) | Verfahren zur Herstellung von Diphenyl-azetidinon-Derivaten | |
| DE2205144C3 (de) | Azetidino [3,2-d] thiazole und Verfahren zu ihrer Herstellung | |
| EP0195963A1 (de) | Verfahren zur Herstellung von Carbapenemzwischenprodukten | |
| DD292460A5 (de) | Verfahren zur herstellung von 1,3-substituiertem tetrahydro-1h-thieno-[3,4-d]-imidazol-2(3h)-on-4-yliden-pentansaeureester | |
| DE3783270T2 (de) | 4 halogen-2-oxyimino-3-oxo-buttersaeure. | |
| DE2539116C2 (de) | &omega;-Nor-cycloalkyl-13,14-dehydro-prostaglandine, Verfahren zu ihrer Herstellung sowie sie enthaltende pharmazeutische Mittel | |
| DE2245560A1 (de) | Verfahren zur herstellung von 4alkoxycarbonyl-2-thiazolinen | |
| EP0222163A1 (de) | Verfahren zur Herstellung von gamma-Butyrolactamen | |
| EP0246534B1 (de) | Enantiomerenreine 4,5-disubstituierte gamma-Butyrolactame, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE3112265C2 (ja) | ||
| DE10331496A1 (de) | Verfahren zum Herstellen von Difluoracetessigsäurealkylestern | |
| WO1983001449A1 (en) | Method for the preparation of intermediary compounds of carbacyclin | |
| DE3338832C2 (ja) | ||
| DE19735578A1 (de) | Neue (C1-C6)-Fragmente, Verfahren zur Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten | |
| AT407638B (de) | Verfahren zur selektiven reduktion von chiralen alpha- oder beta-ketoestern mit nabh4 und (d)- oder (l)- weinsäure | |
| DE69026706T2 (de) | 2-substituierte-2-cyclopentenone und diese als aktive substanzen enthaltende carcinostatika und osteogenesis-promoter | |
| DE2546910C3 (de) | PhosphinylureidopeniciUansäurederivate und ihre Verwendung | |
| EP1373241B1 (de) | Verfahren zur herstellung optisch aktiver dihydropyrone | |
| DE19735574A1 (de) | Neue [C1(Carboxa)-C6]-Fragmente, Verfahren zu ihrer Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten | |
| DD258610A5 (de) | Verfahren zur herstellung von 5r,6s-6-(1r-1-hydroxyethyl)-2-(oxo-3-thiolanylthio)-2-penem-3-carbonsaeuren | |
| EP0065200A2 (de) | Delta-1-Pyrrolin-thiolactimäther und Verfahren zu ihrer Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |